Summary:
Be a part of the future in diabetes research.
If you are an adult with type 2 diabetes mellitus, you may be eligible to take part in a clinical research study called CARMELINA.
The purpose of the CARMELINA Study is to look at the impact of an investigational drug called linagliptin on the long-term occurrence of selected complications of cardiovascular disease in people with type 2 diabetes mellitus receiving standard of care.
Qualified Participants Must:
• Be 18 years of age or older
•
Have been diagnosed with type 2 diabetes mellitus
•
Have been receiving a stable dose of anti-diabetic medication for at least 8 weeks or you have not previously received anti-diabetic treatment
•
Have previously had problems with your heart (cardiovascular disease) and/or kidneys (renal disease)
Qualified Participants May Receive:
The study drug, assessments, and medical care related to the study will be provided at no cost to you.